{"name":"UCB Biopharma S.P.R.L.","slug":"ucb-biopharma-s-p-r-l","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Radiprodil oral","genericName":"Radiprodil oral","slug":"radiprodil-oral","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Radiprodil oral","genericName":"Radiprodil oral","slug":"radiprodil-oral","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQZUR4alR3b0V3YkVZNU1XVldUNnJpRFBvZVJNcTZEV0V6MTJTODh1MWVuZUJVcnRTMzZiWVlGSHVsaHlhTUE5bXlHcTFiNWF4WVVJQlZJWVp3UUVQcURmRlhIdlN1MVhRTmdqTWwtWS13U3M5RHFRdGFqWGVyWkQ5RGNnV2ZJTFlNVlNRRm13?oc=5","date":"2023-12-02","type":"pipeline","source":"Monash University","summary":"Janssen Pharmaceuticals – lupus research - Monash University","headline":"Janssen Pharmaceuticals – lupus research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPWEd2WTAtbGdTNHltc0I3TUhFaHNjYVNuTG9kemlSMUVscnhXS0FJX3I1QktEZ1FxVWhXRHBQVHBoQkgtSW5VeG5Td05oNmo2YVRTYURlZjhXVzlxc04ydy0wT3VmVjNmT29HaXNyZFkwcVFWSEppN0oxWERtUVpzZUc5VEZocllBVFFtandDZmJod2M5UWpLOUdSVUtfQm1GWElucXRxdTJuZG9TVEE?oc=5","date":"2021-08-16","type":"regulatory","source":"lupin.com","summary":"Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets - Lupin | Press Release - lupin.com","headline":"Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets - Lupin | Press Release","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQbTRLbWROalEtZGFsLXJnWnpiRWVqbWY1WDhMSzJNVWVvcXplb0NwUnZ3Ry1MZXRyTzEwWEVwRDd6UktndmVWa2FWVERvQ1NrWmR1bUJtYXktMlNsbUgzRDVKdEZNSmxXLXlIT0pDcmZXUU5xT2lVUnppSGh2U3NRUEkwQ1pORXd5?oc=5","date":"2020-06-10","type":"pipeline","source":"grandviewresearch.com","summary":"Ankylosing Spondylitis Market Size | Industry Report, 2033 - grandviewresearch.com","headline":"Ankylosing Spondylitis Market Size | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9vQXBlcDJ6QTFIcmIwZ0ZoX2l5YmpnXzFzNFVHNmxYUkJOV0xTR0gyODlKb3J1dzZWMmRaSDlOUUNwRlFwVGFCdU5uNUh3SlNtUWRKRHRyVkt3bWp3TnlWVUlKQlg3UzNU?oc=5","date":"2016-12-15","type":"pipeline","source":"Wiley Online Library","summary":"Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions - Wiley Online Library","headline":"Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPdzNKMmhBM2N6S2hscEdHaGJLa08zR1k0Q21SSFFrTkxaSFkySm5SempHYTF3MFZnWU9oT2pOVndiT0U0ZndoWHhHVXlVeENCM2hvS252VWNLLVpabWVCek5kM2lHNlJwT3Z0UXFjMk5rWFl6TkJKeV9uZ0h0aXc3X0VhaEU5SnBnRkcyZTdiOUhiV2RjZ3ZnRU05Qll3UkdENzYzMWI2bndJWktJbXB6NDZtTXFFLVlrX1VGa1hveTFkbU9PbzB2Skt1ZTViZmNVTElfQ2pUV1VsTGJxNXpHZmhMeFdNVkxvWU9Fb1hmLW1yZzVES042Sy1ZZ2E0aWd3REtkOWFxU1NRTm92ckJrUlZn?oc=5","date":"2015-06-16","type":"pipeline","source":"BioProcess International","summary":"Implementing the USP Development - Validation Approach to a Relative Potency Assay - BioProcess International","headline":"Implementing the USP Development - Validation Approach to a Relative Potency Assay","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}